Literature DB >> 27514464

Pharmacogenetics and Personalized Medicine in Pain Management.

Lynn R Webster1, Inna Belfer2.   

Abstract

Genetic research heralds a new therapeutic approach to pain management. Increasing literature demonstrates individual genetic vulnerabilities to specific pain types and mechanisms, partially explaining differing responses to similar pain stimuli. Furthermore, analgesics demonstrate great variability among carriers of different genotypes. Family history and genotyping promise to play an important role in the future approach to pain therapies. As advances continue in the genetics of pain and analgesia, pharmacotherapy will depend more on an individualized, targeted approach and less on empiricism.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytochrome P450 (CYP); Genomic testing; Pain management; Pharmacogenetics; Polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27514464     DOI: 10.1016/j.cll.2016.05.007

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  9 in total

1.  Is Precision Medicine Consistent With Primary Care?

Authors:  Dana E King
Journal:  Fam Med       Date:  2019-03       Impact factor: 1.756

Review 2.  The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Authors:  Shannon M Smith; Robert H Dworkin; Dennis C Turk; Ralf Baron; Michael Polydefkis; Irene Tracey; David Borsook; Robert R Edwards; Richard E Harris; Tor D Wager; Lars Arendt-Nielsen; Laurie B Burke; Daniel B Carr; Amy Chappell; John T Farrar; Roy Freeman; Ian Gilron; Veeraindar Goli; Juergen Haeussler; Troels Jensen; Nathaniel P Katz; Jeffrey Kent; Ernest A Kopecky; David A Lee; William Maixner; John D Markman; Justin C McArthur; Michael P McDermott; Lav Parvathenani; Srinivasa N Raja; Bob A Rappaport; Andrew S C Rice; Michael C Rowbotham; Jeffrey K Tobias; Ajay D Wasan; James Witter
Journal:  J Pain       Date:  2017-02-27       Impact factor: 5.820

3.  Does self-perception of sensitivity to pain correlate with actual sensitivity to experimental pain?

Authors:  Doron Meiselles; Joshua Aviram; Erica Suzan; Dorit Pud; Elon Eisenberg
Journal:  J Pain Res       Date:  2017-11-13       Impact factor: 3.133

4.  CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort.

Authors:  Concetta Dagostino; Massimo Allegri; Valerio Napolioni; Simona D'Agnelli; Elena Bignami; Antonio Mutti; Ron Hn van Schaik
Journal:  Pharmgenomics Pers Med       Date:  2018-10-24

Review 5.  Understanding the Psychological, Physiological, and Genetic Factors Affecting Precision Pain Medicine: A Narrative Review.

Authors:  Andrea Chadwick; Andrew Frazier; Talal W Khan; Erin Young
Journal:  J Pain Res       Date:  2021-10-08       Impact factor: 3.133

6.  Reducing Opioid Prescriptions by Identifying Responders on Topical Analgesic Treatment Using an Individualized Medicine and Predictive Analytics Approach.

Authors:  Jeffrey Gudin; Seferina Mavroudi; Aigli Korfiati; Konstantinos Theofilatos; Derek Dietze; Peter Hurwitz
Journal:  J Pain Res       Date:  2020-05-28       Impact factor: 3.133

7.  The Alpha-2A Adrenergic Receptor Gene -1291C/G Single Nucleotide Polymorphism is Associated with the Efficacy of Methylphenidate in Treating Taiwanese Children and Adolescents with Attention-Deficit Hyperactivity Disorder.

Authors:  Hui-Ching Huang; Lawrence Shih-Hsin Wu; Shun-Chieh Yu; Bo-Jian Wu; Ahai Chang Lua; Shin-Min Lee; Chao-Zong Liu
Journal:  Psychiatry Investig       Date:  2018-02-28       Impact factor: 2.505

8.  Designing and conducting proof-of-concept chronic pain analgesic clinical trials.

Authors:  Claudia M Campbell; Ian Gilron; Tina Doshi; Srinivasa Raja
Journal:  Pain Rep       Date:  2019-02-26

Review 9.  Molecular Basis of Cancer Pain Management: An Updated Review.

Authors:  Ayappa V Subramaniam; Ashwaq Hamid Salem Yehya; Chern Ein Oon
Journal:  Medicina (Kaunas)       Date:  2019-09-12       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.